Participated · Equity · May 2025

Outcomes4Me is a Boston-based, direct-to-patient AI-driven platform that integrates clinical guidelines, genomic insights, clinical trial matching, medication and symptom tracking, and patient peer communities to help patients with cancer navigate care. The company uses patented technology and generates multimodal, patient-level datasets enriched at the drug level to deliver personalized, real-time treatment insights. Since its commercial launch in 2022, Outcomes4Me reports more than 280,000 cancer patients using its platform and an incredible revenue growth trajectory; seven of the top 10 global cancer pharmaceutical companies are among its customers. Outcomes4Me has raised $38M in total capital to date following a $21M round announced May 29, 2025. With the new funding the company plans to accelerate market penetration across additional cancer types and geographies, expand its AI capabilities, and strengthen collaborations with top-tier health systems and life sciences companies. It also intends to scale revenue streams through international expansion and outcomes-based evidence generation and real-world data insights to improve treatment and care. Outcomes4Me has developed an AI-powered patient empowerment platform that combines regulatory-grade, real-world data and patient experiences to generate insights for shared decision-making between patients and providers. The platform currently focuses on breast cancer and aims to improve care, accelerate research and achieve better outcomes. The company was co-founded in 2017 by Maya R. Said, Sc.D. (CEO) and Dr. Osama Rahma (Chief Medical Advisor); Sami Shalabi later joined as COO and brings prior Google leadership experience. Outcomes4Me plans to extend its platform beyond breast cancer to other cancers, grow its regulatory-grade dataset, and expand to more patients in Europe. The company raised $12M in a Series A to support those initiatives, indicating recent capital infusion to fund growth. Outcomes4Me offers a free mobile app and HIPAA-compliant platform that leverages artificial intelligence and machine learning to analyze medical records and provide patients with personalized, actionable information. The app is available on the Apple App Store and Google Play and surfaces resources traditionally targeted to physicians, including NCCN Guidelines and UpToDate drug information. Its technology has been applied to medical records from more than 700 institutions across the United States and Canada, and more than 10,000 breast cancer patients used the app in the past year. Co-founded by Maya R. Said, Sc.D., and Dr. Osama Rahma, the company aims to deliver timely, personalized guidance regardless of patients’ race, socioeconomic status, or location. Outcomes4Me recently added Sami Shalabi, formerly head of engineering and product development at Google, as chief operating officer. The company raised $4.7M to expand its reach to address cancers beyond breast cancer.